Wolff Stefani

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Wolff Stefani's trades of Nurix Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-02 2023-05-01
PlS Planned sale
47,670 -28.7%
136.73
US$4,619,412 		47,670 -28.7% 136.73 US$4,619,412
2023-02-01 2023-01-30
S Sale
9,045 +9.2%
57.43
US$1,140,269 		9,045 +9.2% 57.43 US$1,140,269
2022-11-01 2022-10-31
S Sale
80,301 +19.9%
354.29
US$198,429 		80,301 +19.9% 354.29 US$198,429
2022-08-02 2022-08-01
S Sale
356 -22.3%
15.67
US$5,579 		356 -22.3% 15.67 US$5,579
2022-05-03 2022-05-02
S Sale
330 -34.3%
11.75
US$3,878 		330 -34.3% 11.75 US$3,878
2020-06-17 2020-06-15
PlS Planned sale
100 -0.5%
61.37
US$6,137 		100 -0.5% 61.37 US$6,137
2020-06-17 2020-06-15
PlS Planned sale
5,004 -20.7%
60.81
US$304,291 		5,004 -20.7% 60.81 US$304,291
2020-06-17 2020-06-15
PlS Planned sale
400 -1.6%
59.89
US$23,957 		400 -1.6% 59.89 US$23,957
2020-03-18 2020-03-16
PlS Planned sale
3,750 -9.5%
46.36
US$173,838 		3,750 -9.5% 46.36 US$173,838
2020-03-18 2020-03-16
PlS Planned sale
1,754 -4.3%
45.72
US$80,192 		1,754 -4.3% 45.72 US$80,192